Resultado da Busca
Há 5 dias · New polio vaccines are key to preventing outbreaks and achieving eradication. To reach the goal of polio eradication, we can use new vaccines to contain outbreaks and improve testing, outbreak responses, and sanitation. By Saloni Dattani — May 27, 2024.
- Our Latest Work
Licenses: All visualizations, data, and articles produced by...
- Our Latest Work
Há 5 dias · This study explores excess mortality in the Western World from 2020 until 2022.Methods All-cause mortality reports were abstracted for countries using the ‘Our World in Data’ database. Excess mortality is assessed as a deviation between the reported number of deaths in a country during a certain week or month in 2020 until 2022 and the expected number of deaths in a country for that period ...
Há 1 dia · The authors of the new study, published in BMJ Public Health, used publicly available data from Our World in Data to determine which countries had “statistically significant” excess deaths ...
Há 2 dias · “As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting.” Passages like this remind us about the colossal value observational data can have for moving our societies forward.
Há 2 dias · The COVID-19 pandemic prompted governments worldwide to implement a range of containment measures, including mass gathering restrictions, social distancing, and school closures. Despite these efforts, vaccines continue to be the safest and most effective means of combating such viruses. Yet, vaccine hesitancy persists, posing a significant public health concern, particularly with the emergence ...
Há 5 dias · Every year, vaccines save millions of lives, and millions more people are protected from disease and disability. By preventing many serious early-childhood infectious diseases, like polio and measles, immunization helps children grow into healthy adults.
Há 5 dias · Moderna’s Spikevax, another vaccine for COVID-19, had sales of $6.6 billion in 2023—also far below its peak sales of $21.8 billion in 2022 1. GSK brought in the second-highest revenues in the ...
